Allergios
PrivateLast Round
Grant
Oct 10, 2024
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Allergios is a medical technology company that develops an AI-powered microfluidic platform for functional allergy diagnostics, aiming to replace traditional oral provocation tests.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allergios Comparables
Compare Allergios with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bioherent | 81% | |
| BÜHLMANN Laboratories AG | 72% | |
| Thermo Fisher Scientific Inc. | 72% |
Allergios Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 10, 2024 | ||||
| Seed | May 23, 2022 |
Allergios Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NLC Health Ventures | Seed |
| Health~Holland | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 311% MoM.
- May 23, 2022
NLC Health Ventures participated in the Seed round.
Allergios Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Allergios's valuation, stock price, and market status.
Is Allergios a public or private company?
Allergios is a private company.
What is the current stock price of Allergios?
Allergios is a private company with no public stock price. No recent secondary market data is available.
How much is Allergios worth (valuation)?
Valuation information for Allergios is not publicly available.
Can I buy Allergios stock?
Allergios shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Allergios's last funding round?
Allergios's most recent funding round was Grant on October 10, 2024.
Who are the main investors in Allergios?
Key investors in Allergios include NLC Health Ventures, Health~Holland.
Will Allergios IPO soon?
No public IPO plans have been announced for Allergios.
How can I track Allergios secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Allergios's secondary market activity and sign up for updates.